Across the city, leading science companies and innovation parks will open their doors to showcase the cluster’s contribution to STEM innovation in the UK and strengthen its diverse, equitable and inclusive community.
News
Key executive appointment provides extensive financial industry experience as the Company implements ambitious global growth strategy
Nottingham-based Contract Research Organisation (CRO) Cellomatics Biosciences has announced the appointment of Professor David Lambert, FRCA and FFPMRCA as Chief Scientific Officer (CSO).
Based in Nottingham, Cellomatics is a specialist preclinical CRO with expertise in five main therapeutic areas: oncology, immuno-oncology, immunology, inflammation and respiratory. Founded in 2015, Cellomatics has since positioned itself as the CRO of choice for its growing global client base seeking expert support with the development of bespoke bioassays.
AMSBIO announce MatriMix – a groundbreaking 3D culture substrate. This pioneering hydrogel sets a new benchmark in the field, containing fully defined components, including medical grade collagens, laminin-511 E8 fragments, and hyaluronic acid. The high lot-to-lot consistency of MatriMix enables researchers to obtain highly reproducible results.
Check out this month's People Pathways newsletter where you can read about:
Experience the ‘Agile’ way of thinking in this practical taster session and find out how Agile project management can boost efficiency, help reduce costs and promote continuous improvement. The session is planned for Thursday July 6 at St John's Innovation Centre, Cambridge.
Qualified Scrum Master and Scrum Coach from Hethel Innovation, Sam Payne, will lead you through the basic principles of ‘Agile’ project management to give you an insight into the Agile approach to achieving your business goals.
Attracting and retaining talent in STEM is business critical.
According to almost three-quarters of global senior leaders, talent and skills shortages are the greatest barrier to business strategy over the next 12 months.
In this competitive and skills-short market, understanding current salary levels can unlock better recruitment outcomes faster to help you retain, and attract the most skilled talent.
Kadans Science Partner will add Windrush Innovation Centre in Oxford, UK to its Pan-European portfolio. The asset will be freehold acquired from Tozi Limited. Kadans intends to demolish the existing building and create over 60,000 sq ft of new high specification laboratory and office space in partnership with the tenant, Oxford Biomedica.
PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases
YouGov, on behalf of Bidwells, are carrying out a survey of the Tech sector.
The purpose of the study is to help the real estate sector and policy makers understand the requirements and preferences of organisations so they might better provide property and infrastructure for your industry in the future.
The survey looks at the location and property requirements of the tech sector overall. There are also some additional questions for companies, currently or potentially, working in the areas of health and life sciences.